Fused heterocyclic compounds
AssigneeAmgen Inc.
InventorsXiaoqi Chen, Pingchen Fan, Juan Jaen, Leping Li, Mike Lizarzaburu, Jeffrey Thomas Mihalic, Stephen Joseph Shuttleworth
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds having the formula: wherein R1, R2, R, R′ and the subscript p are described herein. The compounds are useful in the treatment and/or prevention of a condition or disorder mediated by a G-protein coupled receptor. Pharmaceutical compositions and methods of using these compounds for the treatment and/or prevention of a condition or disorder mediated by a G-protein coupled receptor, such as eating disorder, obesity, anxiety disorders and mood disorders are also provided.
Claims2
A compound or a pharmaceutically acceptable salt, hydrate, solvate or prodrug thereof, wherein said compound is selected from the group consisting of:
Dependencies are inferred from the claim text.